Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome

Post Thrombotic Syndrome Clinical Trial

— SEvERe-PTS  

Official title:

Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome Pilot Study and Randomised Control Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05744843
• Other study ID #: 315612
• Status: Recruiting
• Phase: N/A
• Start date: September 5, 2023
• Est. completion date: April 2026

Study information

• Verified date: February 2023
• Source: Guy's and St Thomas' NHS Foundation Trust
• Contact: Ehsanul K Choudhury, MRCS
• Phone: +44 20 7188 7188
• Email: ehsanul.choudhury[@]gstt.nhs.uk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this pilot study and randomised control trial is to compare a smartphone-based exercise programme to deep venous stenting in patients with Post Thrombotic Syndrome. The main questions it aims to answer are: - Is exercise as effective as stenting in these patients? - What type of exercise is useful in these patients? - Can exercise be used to improve the results from surgery? Participants will be split into two groups at random. They will complete a smartphone-based exercise programme or have a deep venous stent. They will do the following tests before and after. - Exercise testing - Calf muscle strength and function tests - Ultrasound of the deep veins - Quality of life questionnaires - Clinical assessment of their disease They will be compared to healthy volunteers in the pilot study. Investigators will compare exercise to stenting to see if it improves symptoms in these patients. The pilot study will help decide how many patients are needed and what exercise tests will be used for the Randomised control trial.

Description:

This is a non-commercial pilot study, leading to a randomised control trial. Primary objective: 1) To evaluate smartphone-based exercise as an alternative to stenting in patients with IVC and Iliofemoral vein outflow obstruction secondary to Post Thrombotic Syndrome (PTS). Secondary objectives: 1. To characterise symptomatology and response to different exercise modalities in patients with chronic venous insufficiency. 2. Evaluate exercise physiology in patients with chronic venous insufficiency before and after a supervised exercise programme. 3. To explore the use of available technologies, such as smart phone applications and wearable devices to deliver a remotely monitored exercise programme. 4. To establish a method of assessment of flow (inflow and collateral flow) in patients with symptomatic venous obstruction. 5. To understand the impact of stent shape and compression on venous flow and the subsequent patient outcomes. 6. To set criteria for the stratification of patient treatment based upon objective and quantitative measures in patients with venous claudication. Participants will be recruited to the following three groups: Group 1. Patients with PTS that will undergo remotely supervised exercise Group 2. Patients with PTS that will undergo stenting Group 3. Healthy volunteers All participants will undergo series of exercise tests and imaging assessments. Participants in group 1 will have these tests repeated at the end of the exercise programme, and group 2 when they attend for their six to eight week follow up visit. Participants in group 1 will be able to re-join the waiting list for stenting on the condition that they have agreement from their named consultant. Investigators anticipate all study activities to be completed before group 1 participants would have received a date for stenting, as current waiting times for stenting is in excess of 18 months. Patients from both groups 1 and 2 will be loaned an activity tracker (FitBit) to wear. Group 1 will be asked to wear the tracker from day 1 of the exercise programme, group 2 will be asked to wear the tracker from the first post operative day. Both groups will wear the tracker until the follow up visit. This will allow measurement of general activity in both groups and allow for monitoring of compliance with exercise in group 1.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 54
• Est. completion date: April 2026
• Est. primary completion date: October 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with symptomatic chronic venous outflow obstruction secondary to PTS or other cause affecting the Inferior Vena Cava (IVC) or iliofemoral vein(s) for greater than 12 months duration AND clinical indication for Deep Venous Stenting.

Exclusion Criteria:

• Deep Vein Thrombosis or Pulmonary Embolism within the last 12 months
• Significant or untreated left sided heart disease
• Significant or untreated respiratory disease
• Significant renal disease
• Significant liver disease
• Significant Musculoskeletal or Neurological disease
• Active cancer
• Life expectancy of less than 2 years or non-ambulatory status
• Current or Planned pregnancy within the study period
• Any other contraindication to exercise
• Any impairment preventing the provision of informed consent and compliance with study protocol
• Healthy Volunteers in the control group with presence of any arterial or venous disease

Related Conditions & MeSH terms

• Post Thrombotic Syndrome
• Postphlebitic Syndrome
• Postthrombotic Syndrome
• Syndrome

Intervention

Behavioral:
• exercise
cardiovascular and lower limb strengthening exercise programme

Procedure:
• Deep venous stenting
Planned surgical intervention

Locations

Country	Name	City	State
United Kingdom	St. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust	London

Sponsors (1)

Lead Sponsor	Collaborator
Guy's and St Thomas' NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Maximal calf isometric contract strength as measured by isometric dynamometry.	Change in calf muscle maximal force output, greater output indicates improvement	1) Day 0 - baseline, prior to intervention. 2) up to 2 weeks post intervention, on average week 8-12 of the study.
Other	deep venous flow velocity	changes in ultrasound assessed venous flow	1) Day 0 - baseline, prior to intervention. 2) up to 2 weeks post intervention, on average week 8-12 of the study.
Primary	Villalta score.	0-30, >5 diagnostic of post thrombotic disease. 5-9 is mild disease, 9-4 moderate and >15 Severe. (15 automatically added in the presence of a venous leg ulcer). Change in Villalta score	1) Day 0 - baseline, prior to intervention. 2) up to 2 weeks post intervention, on average week 8-12 of the study. 3) Study completion, 6 months
Secondary	VO2 max - maximal oxygen consumption	change in peak VO2 max on cardiopulmonary exercise testing. Increased value indicates improvement, decreased value indicates deterioration	1) Day 0 - baseline, prior to intervention. 2) up to 2 weeks post intervention, on average week 8-12 of the study.
Secondary	Six minute walk test	change in six minute walk test. Increased distance indicates improvement, decreased distance indicates deterioration.	1) Day 0 - baseline, prior to intervention. 2) up to 2 weeks post intervention, on average week 8-12 of the study.
Secondary	Incline walk test	Time to onset of symptoms and total incline and speed achieved. Longer time to onset, steeper incline achieved and faster speed acheived indicate improvement.	1) Day 0 - baseline, prior to intervention. 2) up to 2 weeks post intervention, on average week 8-12 of the study.
Secondary	Calf ejection fraction	change in calf ejection fraction by plethysmography	1) Day 0 - baseline, prior to intervention. 2) up to 2 weeks post intervention, on average week 8-12 of the study.
Secondary	Venous Insufficiency Epidemiological and Economic Study quality of life and symptoms (VEINES-QoL/Sym) - disease specific quality of life instrument for Chronic Venous Disorders of the Leg	Change in VEINES-QoL/Sym score - higher value indicates better outcome	1) Day 0 - baseline, prior to intervention. 2) up to 2 weeks post intervention, on average week 8-12 of the study. 3) Study completion, 6 months